VF
STLN

Virtu Financial’s Starling Oncology STLN Stock Holding History

Virtu Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,213
Closed -$41K – 2244
2026
Q1 		$41K Buy
+13,213
New +$40.5K ﹤0.01% 1317
2025
Q1 		– Sell
-131,759
Closed -$41K – 2033
2024
Q4 		$41K Buy
+131,759
New +$34.2K ﹤0.01% 1188
2023
Q4 		– Sell
-14,044
Closed -$20K – 2005
2023
Q3 		$20K Buy
+14,044
New +$14.5K ﹤0.01% 1017

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial's STLN Position: Q2 2026 in Review

Virtu Financial sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 13,213 shares — an estimated $41K sold.

Virtu Financial first reported a position in STLN in Q3 2023 and held it in 3 quarters. The position peaked at $41K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Virtu Financial reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 13,213 Starling Oncology shares in Q2 2026, an estimated $41K.
  • Virtu Financial first reported a position in Starling Oncology in Q3 2023 and held it in 3 quarters.
  • Virtu Financial's Starling Oncology position peaked at $41K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.